YUHSpace: Durvalumab +/− Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase III POSEIDON Study

YUHSpace

BROWSE

0 251

Cited 0 times in

Cited 0 times in

Durvalumab +/− Tremelimumab + Chemotherapy as First-line Treatment for mNSCLC: Results from the Phase III POSEIDON Study

Authors: N Reinmuth ; M L Johnson ; B C Cho ; A Luft ; J A Alatorre-Alexander ; S L Geater ; K Laktionov ; A Vasilyev ; D Trukhin ; S W Kim ; G Ursol ; M Hussein ; F L Lim ; C T Yang ; L H Araujo ; H Saito ; X Shi ; L Poole ; S Peters ; E B Garon ; T Mok ; J Rawluk

Citation: PNEUMOLOGIE, Vol.76(Suppl 1) : S48, 2022-05

Journal Title: PNEUMOLOGIE

Issue Date: 2022-05

Full Text: https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0042-1747796

DOI: 10.1055/s-0042-1747796

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

URI: https://ir.ymlib.yonsei.ac.kr/handle/22282913/194456

사서에게 알리기

Show full item record Find it @ YMLIB

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

License

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links